Amazon Acetaminophen Recall Aurobindo Pharma: Over 112,000 Bottles Pulled Following Reports Of Discoloured Tablets

A major pharmaceutical manufacturer has triggered a voluntary nationwide recall of more than 112,000 bottles of Amazon-branded acetaminophen following widespread consumer complaints regarding discoloured tablets. Aurobindo Pharma USA Inc. initiated the withdrawal of the over-the-counter pain medication, sold exclusively under the Amazon Basic Care label, as federal health regulators evaluate the potential risks associated with the defective batches. The mass withdrawal highlights ongoing quality assurance challenges within the rapidly expanding market of e-commerce private-label pharmaceuticals.

Amazon Acetaminophen Recall Aurobindo Pharma: What Prompted The Voluntary Medication Recall?

The sweeping recall was formally initiated in late September after an influx of consumer complaints indicated that the 500-milligram Extra Strength Acetaminophen caplets exhibited abnormal physical discolouration. Acting swiftly to mitigate any potential risk, Aurobindo Pharma moved to pull exactly 112,932 bottles from circulation across the US market.